DK3222286T3 - Anvendelse af alkalisk phosphatase til bevaring af nyrefunktion - Google Patents

Anvendelse af alkalisk phosphatase til bevaring af nyrefunktion Download PDF

Info

Publication number
DK3222286T3
DK3222286T3 DK17158127.5T DK17158127T DK3222286T3 DK 3222286 T3 DK3222286 T3 DK 3222286T3 DK 17158127 T DK17158127 T DK 17158127T DK 3222286 T3 DK3222286 T3 DK 3222286T3
Authority
DK
Denmark
Prior art keywords
preservation
alkaline phosphatase
kidney function
kidney
function
Prior art date
Application number
DK17158127.5T
Other languages
English (en)
Inventor
Jacques Salomon Robert Arend
Den Berg Erik Jan Van
Willem Raaben
Original Assignee
Am Pharma Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Am Pharma Bv filed Critical Am Pharma Bv
Application granted granted Critical
Publication of DK3222286T3 publication Critical patent/DK3222286T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/465—Hydrolases (3) acting on ester bonds (3.1), e.g. lipases, ribonucleases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y301/00—Hydrolases acting on ester bonds (3.1)
    • C12Y301/03—Phosphoric monoester hydrolases (3.1.3)
    • C12Y301/03001—Alkaline phosphatase (3.1.3.1)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/483—Physical analysis of biological material
    • G01N33/487—Physical analysis of biological material of liquid biological material
    • G01N33/49—Blood
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Physics & Mathematics (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biochemistry (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Urology & Nephrology (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Analytical Chemistry (AREA)
  • Ecology (AREA)
  • Genetics & Genomics (AREA)
  • General Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DK17158127.5T 2011-06-08 2012-06-08 Anvendelse af alkalisk phosphatase til bevaring af nyrefunktion DK3222286T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP11169143 2011-06-08
EP12729755.4A EP2717906B1 (en) 2011-06-08 2012-06-08 The use of alkaline phosphatase for preserving renal function

Publications (1)

Publication Number Publication Date
DK3222286T3 true DK3222286T3 (da) 2020-11-09

Family

ID=46354459

Family Applications (2)

Application Number Title Priority Date Filing Date
DK17158127.5T DK3222286T3 (da) 2011-06-08 2012-06-08 Anvendelse af alkalisk phosphatase til bevaring af nyrefunktion
DK12729755.4T DK2717906T5 (da) 2011-06-08 2012-06-08 Anvendelse af alkalisk phosphatase til bevaring af nyrefunktion

Family Applications After (1)

Application Number Title Priority Date Filing Date
DK12729755.4T DK2717906T5 (da) 2011-06-08 2012-06-08 Anvendelse af alkalisk phosphatase til bevaring af nyrefunktion

Country Status (7)

Country Link
US (3) US20140219984A1 (da)
EP (2) EP3222286B1 (da)
DK (2) DK3222286T3 (da)
ES (2) ES2618794T3 (da)
HU (1) HUE052383T2 (da)
PL (2) PL2717906T3 (da)
WO (1) WO2012169892A2 (da)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2624905T3 (es) 2004-02-04 2017-07-18 Am-Pharma B.V. Uso de fosfatasa alcalina para la desintoxicación de LPS
US20130261412A1 (en) * 2012-03-28 2013-10-03 II Robert Lawrence Reed System and method for managing fluid levels in patients based upon creatinine clearance
CN111778228A (zh) 2014-01-24 2020-10-16 安-法玛公司 嵌合型碱性磷酸酶样蛋白
US10570380B2 (en) * 2014-01-24 2020-02-25 Am-Pharma B.V. Downstream processing of an alkaline phosphatase
WO2016030711A1 (en) * 2014-08-25 2016-03-03 Diasys Diagnostics India Private Limited Stable phosphatase substrate formulation and uses thereof
WO2019139891A1 (en) 2018-01-09 2019-07-18 Synthetic Biologics, Inc. Alkaline phosphatase agents for treatment of neurodevelopmental disorders
PL3762018T3 (pl) * 2018-03-08 2024-06-17 Am-Pharma B.V. Zrekombinowana fosfataza alkaliczna do zastosowania w leczeniu ostrego uszkodzenia nerek związanego z sepsą
CA3094173A1 (en) 2018-03-20 2019-09-26 Synthetic Biologics, Inc. Intestinal alkaline phosphatase formulations
EP4275761A3 (en) 2018-03-20 2024-02-28 Theriva Biologics, Inc. Alkaline phosphatase agents for treatment of radiation disorders
US20240009280A1 (en) 2020-09-09 2024-01-11 Am-Pharma B.V. Recombinant alkaline phosphatase for use in treating acute respiratory distress syndrome

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007075199A1 (en) * 2005-12-28 2007-07-05 Zoltan Laboratories Llc Use of alkaline phosphatase to maintain healthy tissue mass in mammals
US7718170B2 (en) * 2006-08-21 2010-05-18 Essential Skincare, Llc Alkaline phosphatase compositions to reduce skin cancer
EP1952823A1 (en) * 2007-01-30 2008-08-06 AM-Pharma B.V. The use of alkaline phosphatase in the treatment of reduced renal function
EP1985697A1 (en) 2007-04-27 2008-10-29 AM-Pharma B.V. Modified phosphatases

Also Published As

Publication number Publication date
DK2717906T3 (da) 2017-03-20
EP3222286A1 (en) 2017-09-27
EP3222286B1 (en) 2020-10-21
EP2717906B1 (en) 2017-03-01
WO2012169892A3 (en) 2013-03-14
ES2618794T3 (es) 2017-06-22
ES2828987T3 (es) 2021-05-28
PL2717906T3 (pl) 2017-06-30
WO2012169892A2 (en) 2012-12-13
US20190209662A1 (en) 2019-07-11
DK2717906T5 (da) 2017-06-19
HUE052383T2 (hu) 2021-04-28
PL3222286T3 (pl) 2021-04-06
EP2717906A2 (en) 2014-04-16
US20160250299A1 (en) 2016-09-01
US20140219984A1 (en) 2014-08-07

Similar Documents

Publication Publication Date Title
DK3222286T3 (da) Anvendelse af alkalisk phosphatase til bevaring af nyrefunktion
DK2841623T3 (da) Fremgangsmåder til fremstilling af lithiumhydroxid
DK2768857T3 (da) Fremgangsmåder til oprensning af antistoffer
DK2766392T3 (da) Fremgangsmåde til oprensning af antistoffer
CO6940421A2 (es) Inhibidores de neprilisina
CR20140147A (es) Inhibidores de aplicación viral
DK2906696T3 (da) Fremgangsmåder til modulering af c9orf72-ekspression
DE112012003620T8 (de) Kartusche
CO6781518A2 (es) Inhibidores de neprilisina
DK3520805T3 (da) Sammensætninger til behandling af myelofibrose
DK3512197T5 (da) Fremgangsmåde til kortlægning af intraprædikationsmodus
DK3357511T3 (da) Inhibitorer af t-celleaktivering
DK2665486T3 (da) Sammensætninger til modulering af gamma-c-cytokin-aktivitet
DK2802865T3 (da) Overvågning af motorkomponenter
DK2785801T4 (da) Fremgangsmåde til formindskelse af isdannelse på et underlag
DK3396980T3 (da) Binaural kompressor til opnåelse af retningsanvisninger
FR2996411B1 (fr) Piege pour frelons
DK2969098T3 (da) Fremgangsmåder til oprensning af antistoffer
CO6842023A2 (es) Composición herbicida
DK2931313T3 (da) Opløsningsformuleringer af manipulerede anti-il-23p19-antistoffer
DK2836460T3 (da) Fremgangsmåde til fremstilling af graphen
DK2870252T3 (da) Fremgangsmåder ved anvendelse af patatin
CL2014002034A1 (es) Compuestos derivados de isoxazol-fenil-azetidina fenil sustituidos; y compuestos intermediarios.
DK2788353T3 (da) Bur-aminligander til metallo-radiofarmaceutika
DK2701707T3 (da) Fremgangsmåde til behandling af dyskinesi